Objective: Stent graft-induced new entry (SINE) has been increasingly observed after thoracic endovascular aortic repair (TEVAR) for Stanford type B aortic dissection. SINE is often life threatening, and reintervention is required. This study investigated risk factors for SINE after TEVAR.
Aortic dissection, whether acute or chronic, is a potentially life-threatening disease. Conventional treatments for aortic dissection include open thoracotomy and aortic replacement with a prosthetic graft, with a few indications for surgical repair. However, most affected patients are elderly and present with various high-risk factors, including hypertension, cardiovascular disease, and respiratory diseases, leading to increased postoperative morbidity and mortality rates. 1 Endovascular stent graft repair was introduced in 1992 as an alternative treatment option to conventional open surgery for Stanford type B aortic dissection. 2 Currently, thoracic endovascular aortic repair (TEVAR) is increasingly used. This procedure has contributed significantly to the field of thoracic aortic surgery [3] [4] [5] ; however, its long-term durability in the treatment of aortic dissection remains a concern.
The stent graft used in the repair has the potential to cause intimal injury to the aorta and may result in new aortic dissection or pseudoaneurysm formation at the proximal or distal end of the stent graft. Stent graftinduced new entry (SINE), which is defined as a new intimal tear caused by the stent graft, is a major complication related to TEVAR in aortic dissection. [6] [7] [8] Weng et al 6 reported that the incidence of new entry tear at the distal margin of the stent graft reached 27.3%, with 30.0% needing reintervention for complicated distal SINE. 6 SINE is generally believed to occur in cases of acute aortic dissection because the dissected intimal membrane is more fragile in acute dissection than in chronic dissection. 9 However, a high incidence of SINE has also recently been reported in patients with chronic aortic dissection. 7, [10] [11] [12] Meanwhile, several reports have suggested that early intervention may lead to results that are more favorable. [12] [13] [14] Thus, this study was conducted to analyze whether the risk of SINE is higher in patients with chronic aortic dissection than in those with acute aortic dissection. We also investigated whether other risk factors may be predictive of SINE.
METHODS
This retrospective study was approved by the Yonsei University Institutional Review Board. Neither patient approval nor informed consent was required for review of medical records, computed tomography (CT) images, or aortography images.
Patients. This study included 79 patients (58 men, 21 women) who were a mean age of 56.2 6 13.7 years (range, 25-84 years). These patients underwent TEVAR for Stanford type B aortic dissection at our institute between July 2001 and June 2013. The indications for TEVAR for Stanford type B aortic dissection were impending rupture, malperfusion, refractory hypertension, or hypotension for acute aortic dissection; aortic diameter >55 mm, yearly increase of aortic diameter >4 mm, or recurrent symptoms for chronic aortic dissection. Aortic dissection was defined as acute aortic dissection if occurring #2 weeks from the initial onset of symptoms and defined as chronic dissection if occurring >2 weeks of initial symptom onset.
Stent graft systems. Four types of stent graft were deployed among the 79 patients with Stanford type B aortic dissection: Separate Stent-Graft (S&G Biotech Inc, Seongnam, Korea) in 25, SEAL (S&G Biotech Inc) in 42, Zenith TX2 (Cook Inc, Bloomington, Ind) in 3, and Valiant (Medtronic, Minneapolis, Minn) in 9. The Valiant and SEAL stent grafts have proximal bare portion and the Separate Stent-Grafts have proximal and distal bare portion. The SEAL thoracic stent graft has been used since November 2005. It has a flexible body and inwardly bent stent margin to minimize stent graft irritation of the aortic wall. We evaluated the effect of this stent graft modification of the SEAL thoracic stent graft on development of new intimal tear after stent graft treatment of aortic dissections.
TEVAR procedures. TEVAR procedures were performed under general or local anesthesia. Vascular access was achieved using a transfemoral technique, and digital subtraction angiography was performed. On digital subtraction angiography and CT angiography before TEVAR, we evaluated the primary entry tear and re-entry tear site. If the entry and reentry tear were both located in the descending thoracic aorta, one or more stent grafts were positioned to cover both tear sites. If only the entry tear was located in the descending thoracic aorta and the re-entry tear was located in the abdominal aorta or iliac artery, one stent graft was used to cover only the entry tear site. To achieve durable seal of the primary intimal tear, devices were oversized by 10% with respect to the diameter of the aorta just proximal to the dissection, and a locally available commercial stent graft of appropriate size was used.
Before TEVAR procedures, two patients underwent arch vessel debranching to secure a sufficient proximal landing zone. Technical success was 97.5% (77 of 79 patients) and was defined as deployment of the stent graft in the thoracic aorta as planned without angiographic evidence of patent flow through the primary entry tear. There were two technical failures: one stent graft misplacement and one stent graft kinking, which resulted in open surgical aortic repair. Adverse clinical events were recorded during the admission period after the procedure and during ongoing follow-up. After the procedure, a symptomatic ischemic stroke occurred in one patient, and renal infarction developed in another patient.
Evaluation and follow-up imaging protocols. CT angiography, which was reconstructed in three dimensions, and aortography were performed before the procedure. CT scans included the entire aorta, bilateral carotid arteries, and iliac arteries. Postprocedural CT angiography was performed #1 month, at intervals of 3 to 6 months for 2 years, and annually thereafter. The overall size of the aorta, diameter of the true and false lumens, flow patency of true and false lumen, endoleaks, and stent graft characteristics were evaluated using multiplanar reconstruction images of CT angiography. The mean follow-up period was 52.7 6 36.8 months.
Treatment of SINE. Surgical aortic graft replacement was the treatment of choice for proximal SINE causing retrograde Stanford type A aortic dissection, and medical treatment was considered if it was minimal and stable. For distal SINE, medical management was the first treatment option. The indications for reintervention of the distal SINE were progressively increasing size of the false lumen, rupture of the false lumen, pseudoaneurysm formation, or dynamic obstruction of the true lumen by the expanding false lumen causing malperfusion of vessel originating from true lumen. (1) taper ratio, which represents the ratio between the size of the true lumen of the presumed proximal and distal landing zone of stent graft before TEVAR; and (2) oversizing ratio, which represents the ratio between the distal size of the selected stent graft and the size of true lumen of the presumed distal landing zone of stent graft before TEVAR.
Xp is the size of the presumed proximal landing zone of the stent graft before TEVAR, Xd is the size of the presumed distal landing zone of stent graft after TEVAR, and Xg is the distal size of the selected stent graft. The size means the maximal diameter, minimal diameter, mean diameter, circumference, area of true lumen and selected stent graft. Taper ratio and oversizing ratio were calculated with each of the five parameters.
Statistical analysis. Statistical analyses were completed using SPSS 20.0 software (IBM Corp, Armonk, NY). Categoric variables were analyzed using the Pearson c 2 test or the Fisher exact test. Continuous variables, expressed as mean 6 standard deviation or median (minimal value-maximal value), were compared using independent t-test or the Mann-Whitney U test, respectively. The cumulative incidence of SINE after TEVAR was estimated by using the Kaplan-Meier method, and the difference of incidence between each group was assessed by using the log-rank test. For the purpose of Kaplan-Meier analysis, taper ratios and oversizing ratios that had a significant univariate association with SINE were dichotomized with respect to cutoff values. The cutoff values were estimated from the receiver operating characteristic (ROC) using the Youden J statistic, which can identify the optimum threshold maximizing the sum of sensitivity and specificity. Patients who died before SINE were censored at death, and patients without SINE were censored at the last date of follow-up. Thereafter, multivariate analysis was performed using Cox proportional hazards regression model for variables with a P value of <.05 at univariate analysis to identify independent predictors of the development of SINE. P values of <.05 were considered statistically significant.
RESULTS
Characteristics of the overall cohort and characteristics of the SINE and non-SINE subgroups are summarized in Tables I and II . TEVAR was performed in 79 patients for acute (n ¼ 17) or chronic (n ¼ 62) Stanford type B aortic dissection. The mean time to TEVAR after the diagnosis of acute aortic dissection was 11.1 6 6.70 days and the median time to TEVAR after chronic aortic dissection was 16.0 months (interquartile range, 1.1-57.2 months). The mean proximal and distal diameters of the stent graft were 34.3 6 4.6 mm (range, 26-46 mm) and 33.0 6 4.0 mm (range, 26-46 mm), respectively.
During the mean follow-up period of 52.7 6 36.8 months, acute stroke developed soon after TEVAR in one patient. Another patient, whose kidney was supplied from the false lumen of the aorta, developed renal infarction after thrombus formation in the false lumen. After a mean follow-up interval of 23.5 months, four patients (5.1%) died: 1 of sepsis, 1 of iliac aneurysmal rupture, and 2 of aortoesophageal fistula.
SINE was detected in 21 patients (26.6%) during the follow-up period of 29.7 6 16.4 months (range, 7 days-5.4 months). SINE developed at the proximal margin of the stent graft in four patients (19.0%) and at the distal margin in 17 (81.0%). Eleven patients did not undergo reintervention and were medically treated, and there was no complication after a mean follow-up of 27.5 months after SINE. The other 10 patients (47.6%) underwent surgical graft replacement (n ¼ 4) or additional TEVAR at the distal margin of the stent graft (n ¼ 6; Fig 2) . No secondary SINE development occurred at the distal margin of the additional stent graft. Among the four patients with proximal SINE, two underwent surgical aortic graft replacement due to saccular aneurysmal formation at proximal stent margin and two due to retrograde Stanford type A aortic dissection. The other two patients with proximal SINE were treated medically because the new entry tears were small and stable. Among 17 patients with distal SINE, nine patients were treated medically, and the other patients underwent additional TEVAR at the distal margin of the stent graft (n ¼ 6) or surgical graft replacement (n ¼ 2) for the following reasons: dynamic obstruction of true lumen by expansion of false lumen due to SINE (n ¼ 1), rupture of the false lumen and pseudoaneurysm formation (n ¼ 1), and progressive increase of the false lumen with SINE (n ¼ 6).
The incidence of SINE after TEVAR was significantly higher in chronic aortic dissection than in acute aortic dissection (32.3% vs 5.9%; P ¼ .032), and Kaplan-Meier curves were significantly different between the acute and chronic aortic dissection group (Fig 3, A) . The incidence of SINE between the Separate Stent-Graft and SEAL groups was not significantly different (36.0% vs 23.8%; P ¼ .284), and Kaplan-Meier curves were also not significantly different between these two groups (Fig 3, B) .
The taper ratio of the stent graft by maximal diameter, mean diameter, circumference, and area was significantly higher in the SINE group than in the non-SINE group (Table II) . The cutoff values for the prediction of SINE after TEVAR were 26.1%, 48.0%, 40.8%, and 72.9% for maximal diameter, mean diameter, circumference, and area (Table III) . The oversizing ratio of the stent graft by maximal diameter, mean diameter, circumference, and area was also significantly higher in the SINE group than in the non-SINE group (Table II) . The cutoff values for predicting post-TEVAR SINE were 43.8%, 108.8%, 87.0%, and 335.9% for maximal diameter, mean diameter, circumference, and area, respectively, as suggested with ROC curve analysis (Table III) . Kaplan-Meier curves were significantly different for all of these eight parameters (P < .0005 to .003; Fig 4) . The results of univariate analysis and multivariate analysis using Cox proportional hazards model, by entering the chronic dissection, stent modification, and taper ratio or oversizing ratio, are reported in Tables IV and V. According to multivariate analysis, the hazard ratios of chronic aortic dissection were 6.30 (95% confidence interval [CI], 0.83-47.74; P ¼ .075) to 7.80 (95% CI, 1.03-59.07; P ¼ .047). The taper ratio and oversizing ratio calculated by maximal diameter, mean diameter, circumference, and area were independent predictors of the development of SINE.
DISCUSSION
Since the introduction of TEVAR as an alternative treatment option for aortic dissection in 1992, 2 several studies have reported various postprocedural complications, including retrograde Stanford type A dissection, stent migration, collapse, stroke, and spinal cord ischemia. [16] [17] [18] [19] [20] [21] SINE is also one of the major complication related to TEVAR and there are several explanations of the cause of SINE. [6] [7] [8] Firstly, the occurrence of new intimal tears after stent graft insertion has been considered to result from a combination of aortic wall fragility and irritation caused by the stent graft. 7 SINE is generally believed to develop in patients with acute aortic dissection, where the wall is more fragile than in chronic aortic dissection 9 ; however, many recent studies have also reported SINE in patients with chronic aortic dissection. 7, [10] [11] [12] These studies have suggested that in the acute phase, the intimal membrane is thinner and stretches more easily, allowing the intimal membrane to expand and recover its original shape more easily after stent graft insertion. In chronic dissection, however, the intimal membrane is thicker and more fibrotic than in acute aortic dissection, resulting in a reduced capacity for remodeling of the true lumen. Thus, in chronic dissection, the expansile force of the stent graft persistently injures the rigid true lumen, which can ultimately lead to more frequent occurrence of new intimal tears than in acute aortic dissection.
Our data indicate the incidence of SINE in Stanford type B aortic dissection is significantly higher in chronic aortic dissection than in acute dissection, and KaplanMeier curves were significantly different between these two groups, which corresponds well with these explanations. On multivariate Cox regression analysis, the hazard ratios of chronic aortic dissection over acute aortic dissection were 6.30 (95% CI, 0.83-47.74; P ¼ .075) to 7.80 (95% CI, 1.03-59.07; P ¼ .047), which were not statistically significant but were marginally significant at the 10% significance level. Because the study population in our study was relatively small (n ¼ 79), further investigation with a larger study population is recommended to Fig 2. A, Multiplanar reconstruction image, (B) axial image, and (C) three-dimensional volume-rendered computed tomography (CT) image of a 53-year-old woman with a Stanford type B chronic descending throacic aortic dissection. D-F, Thoracic endovascular aortic repair (TEVAR) is performed with a 38 Â 150 SEAL stent graft (S&G Biotech Inc, Seongnam, Korea), and the false lumen is completely thrombosed. Distal oversizing ratios of the stent graft by maximal diameter, mean diameter, circumference, and area were 111%, 161%, 146%, and 580%, respectively. G-I, At follow-up 9 months later, small new intimal tear (red arrow) has developed at the distal margin of the stent graft. J-L, An additional 40 Â 110 SEAL stent graft is inserted at the distal margin of the original stent graft, and the distal intimal tear is completely regressed.
validate whether chronic aortic dissection is independent predictor of the development of SINE. We also tried to find the proper timing for TEVAR after chronic aortic dissection; however, our data suggest there is no significant time frame that can minimize the occurrence of SINE.
Secondly, because the aortic arch is included in many of the proximal landing zones for the stent grafts in TEVAR for aortic dissection, the stent graft is bent at the aortic arch. The elastic force of the stent graft as it recovers its original shape injures the aorta at the greater curvature side of the stent graft. 7 In their study, Dong et al 8 reported that all proximal SINE occurred at the greater curvature side. Thus, SINE may occur more frequently when a rigid stent graft with a greater spring back force is used, than when a relatively flexible stent graft is used. In addition, irritation to the intimal flap may be higher if the margin of the stent graft is sharp. However, our results, contrary to expectation, showed that the incidence of SINE does not differ significantly between SEAL stent grafts modified with the flexible body and an inwardly bent stent margin and conventional stent grafts with a proximal, irritating bare portion. Further study is needed to evaluate the effect of stent modification, especially in the subgroup with a stent graft that includes an aortic arch. Thirdly, oversizing of the distal stent graft for the true lumen size may be another cause of the SINE. Oversizing of the stent graft is required to strongly fix stent graft and prevent migration 22 ; however, excessive oversizing of stent grafts leads to excessive radial force, which can be a risk factor for intimal tear. Because stent graft size is selected according to the size of the presumed proximal landing zone and the size of true lumen is much smaller in the distal landing zone than in the proximal landing zone in most cases, the radial force of stent graft on the aortic wall is therefore much greater in the distal landing zone. Our data show SINE developed more frequently at the distal margin of stent graft than at the proximal margin (81.0% vs 19.0%), supporting this mechanism for the development of SINE after TEVAR. In addition, some reports have shown that larger distal oversizing can be a risk factor for a late SINE event. Huang et al 15 reported that the distal oversizing ratio of the stent graft by area was significantly higher in the SINE group than in the non-SINE group (400% vs 198%, respectively; P ¼ .031), and Janosi et al 7 reported that distal oversizing ratio by mean diameter was significantly higher in the SINE group than the non-SINE group (95.9% vs 55.9%, respectively; P < .01). In this study, oversizing ratios calculated from the maximal diameter, mean diameter, circumference, and area were significantly higher in the SINE group than in the non-SINE group, and multivariate Cox regression analysis revealed that these oversizing ratios were independent predictors of the development of SINE. We also evaluated the cutoff values of the oversizing ratio for prediction of SINE after TEVAR using ROC curve analysis. These cutoff values of the oversizing ratio in our study (by a maximal diameter of 43.8%, mean diameter of 108.8%, circumference of 87.0%, and area of 335.9%) were associated with high specificity and negative predictive value for the prediction of a delayed SINE event after TEVAR. Therefore, oversizing the stent graft less than these cutoff values may minimize the risk of SINE after TEVAR. In the case of a highly tapered true lumen, however, we cannot meet these distal oversizing criteria with using single stent graft, because currently commercially available stent grafts taper only 4 mm per segment. Thus, the increased risk for late SINE is inevitable with conventional methods of TEVAR. In our study, the taper ratio between the proximal and distal landing zones of true lumen was higher in the SINE group. To overcome this problem, Feng et al 23 placed an additional restrictive bare stent in the distal part of stent graft and reported a favorable result for reducing the incidence of SINE. In their study, over a mean follow-up period of 39 months, SINE was observed in 2.9% of the conventional TEVAR group; however, over a mean follow-up period of 44.5 months, SINE did not develop in the TEVAR plus restrictive bare stent group. Weng et al 6 suggested overlapping two or more relatively short tapered stent grafts but did not validate the effectiveness of this suggested method. Thus, further investigation is required to evaluate the effectiveness of overlapping tapered stent grafts in the prevention of SINE.
CONCLUSIONS
SINE is a major complication related to TEVAR in Stanford type B aortic dissection, and distal oversizing of the stent graft was an independent predictor of the development of SINE. Appropriate size selection of stent graft without distal oversizing might reduce the risk of late SINE events. The HR (95% CI) and P value of multivariate analysis using parameters in each column.
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